Could HPV (human papilloma virus) vaccine make cervical screening redundant? - Mexico goes first
This article was originally published in Clinica
Will screening for cervical cancer be upstaged by vaccination against the human papilloma virus (HPV), believed to be the leading cause of the disease? Mexico is set to become a test-bed of this possible shift in preventive policy, with potentially major implications for resourcing.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.